Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker ▾	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
ZURA	Zura Bio Ltd Manufacturing · Year ended 2025-12-31 · USD	n/a	-$68.65M	n/a	-67.6%	n/a	-$1.06
ZEOX	Zeo ScientifiX, Inc. Manufacturing · Year ended 2025-10-31 · USD	$5.20M	-$5.52M	-106.2%	n/a	12.5%	-$0.86
XFOR	X4 Pharmaceuticals, Inc Manufacturing · Year ended 2025-12-31 · USD	$35.11M	-$79.20M	-225.6%	-42.5%	n/m	-$1.87
VYGR	Voyager Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$40.37M	-$119.72M	-296.5%	-61.1%	-49.5%	-$2.04
VXRT	Vaxart, Inc. Manufacturing · Year ended 2025-12-31 · USD	$237.26M	$16.33M	6.9%	18.6%	726.7%	$0.07
VOR	Vor Biopharma Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$695.98M	n/a	n/a	n/a	-$70.50
VIVS	VivoSim Labs, Inc. Manufacturing · Year ended 2026-03-31 · USD	$131.0K	-$13.84M	n/m	n/a	-9.0%	-$5.35
VISK	Viskase Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$3.41M	n/a	n/a	n/a	-$0.07
VIR	Vir Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$68.56M	-$437.99M	-638.9%	-57.2%	-7.6%	-$3.16
VCEL	Vericel Corp Manufacturing · Year ended 2025-12-31 · USD	$276.26M	$16.52M	6.0%	4.7%	16.5%	$0.32
TWST	Twist Bioscience Corp Manufacturing · Year ended 2025-09-30 · USD	$376.57M	-$77.67M	-20.6%	-16.4%	20.3%	-$1.30
TVGN	Tevogen Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.28M	n/a	n/a	n/a	-$8.08
TSHA	Taysha Gene Therapies, Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.77M	-$109.00M	n/m	-44.1%	17.3%	-$0.34
TNYA	Tenaya Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$90.60M	n/a	-73.5%	n/a	-$0.59
TIL	Instil Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$71.37M	n/a	-62.7%	n/a	-$10.70
TECX	Tectonic Therapeutic, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$74.15M	n/a	-29.5%	n/a	-$4.05
TECH	Bio-Techne Corp Manufacturing · Year ended 2026-06-30 · USD	$1.22B	$181.86M	15.0%	8.6%	-0.4%	$1.16
TCRX	TScan Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.32M	-$129.77M	n/m	-105.4%	266.7%	-$1.00
TARS	Tarsus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$451.36M	-$66.42M	-14.7%	-19.3%	146.7%	-$1.59
TARA	Protara Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$57.44M	n/a	-29.2%	n/a	-$1.34
STRO	Sutro Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$102.48M	-$191.09M	-186.5%	n/a	65.2%	-$22.49
SRZN	Surrozen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.48M	-$242.03M	n/m	n/a	-67.4%	-$32.37
SRRK	Scholar Rock Holding Corp Manufacturing · Year ended 2025-12-31 · USD	$0	-$377.94M	n/a	-154.0%	n/a	-$3.29
SNTI	Senti Biosciences Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$22.0K	-$61.44M	n/m	n/m	n/a	-$2.73
SLXN	Silexion Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.91M	n/a	-457.6%	n/a	$8.96
SLDB	Solid Biosciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$174.32M	n/a	-96.8%	n/a	-$1.99
SGMOQ	Sangamo Therapeutics, Inc Manufacturing · Year ended 2025-12-31 · USD	$39.55M	-$122.93M	-310.8%	n/a	-31.6%	-$0.44
SCNI	Scinai Immunotherapeutics Ltd. Manufacturing · Year ended 2025-12-31 · USD	$1.31M	-$8.31M	-633.6%	-102.5%	99.2%	n/a
SCLX	Scilex Holding Co Manufacturing · Year ended 2025-12-31 · USD	$30.25M	-$374.05M	n/m	n/a	-46.5%	-$36.48
SANA	Sana Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$244.17M	n/a	-151.8%	n/a	-$0.96
SABS	SAB Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$13.27M	n/a	8.8%	n/a	-$0.79
RXRX	Recursion Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$74.68M	-$644.76M	-863.4%	-57.0%	26.9%	-$1.44
RVMD	Revolution Medicines, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$1.13B	n/a	-69.3%	n/a	-$5.95
RLAY	Relay Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$15.36M	-$276.48M	n/m	-48.8%	53.4%	-$1.61
RGNX	REGENXBIO Inc. Manufacturing · Year ended 2025-12-31 · USD	$170.44M	-$193.88M	-113.8%	-188.7%	104.5%	-$3.76
RGEN	Repligen Corp Manufacturing · Year ended 2025-12-31 · USD	$738.26M	$48.89M	6.6%	2.3%	16.4%	$0.86
REPL	Replimune Group, Inc. Manufacturing · Year ended 2026-03-31 · USD	n/a	-$313.94M	n/a	-188.9%	n/a	-$3.38
QNCX	Quince Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$83.98M	n/a	n/a	n/a	-$1.68
QGEN	Qiagen N.V. Manufacturing · Year ended 2025-12-31 · USD	$2.09B	$424.88M	20.3%	11.2%	5.7%	$1.94
PTHS	Pelthos Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$16.80M	-$43.32M	-257.9%	-111.4%	n/a	-$23.04
PROK	Prokidney Corp. Manufacturing · Year ended 2025-12-31 · USD	$893.0K	-$151.61M	n/m	n/a	n/m	n/a
PRME	Prime Medicine, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.63M	-$201.14M	n/m	-166.4%	55.3%	-$1.35
PMCB	PharmaCyte Biotech, Inc. Manufacturing · Year ended 2026-04-30 · USD	$0	-$19.42M	n/a	-58.3%	n/a	-$2.77
PLX	Protalix BioTherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$52.74M	-$6.60M	-12.5%	-13.7%	-1.2%	-$0.08
PLUR	Pluri Inc. Manufacturing · Year ended 2026-06-30 · USD	$1.02M	-$23.82M	n/m	n/a	-24.0%	-$2.44
PCVX	Vaxcyte, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$766.63M	n/a	-28.5%	n/a	-$5.63
PASG	Passage BIO, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$45.52M	n/a	-242.7%	n/a	-$14.35
PALI	Palisade Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$16.78M	n/a	-13.0%	n/a	-$0.30
OTLK	Outlook Therapeutics, Inc. Manufacturing · Year ended 2025-09-30 · USD	$1.41M	-$62.42M	n/m	n/a	n/a	-$1.79
OCGN	Ocugen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.41M	-$67.85M	n/m	n/a	8.8%	n/a
NVAX	Novavax Inc Manufacturing · Year ended 2025-12-31 · USD	$1.12B	$440.30M	39.2%	n/a	64.7%	$2.58
NMRA	Neumora Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$236.93M	n/a	-228.1%	n/a	-$1.45
NBIX	Neurocrine Biosciences Inc Manufacturing · Year ended 2025-12-31 · USD	$2.86B	$478.60M	16.7%	14.7%	21.4%	$4.67
MRNA	Moderna, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.94B	-$2.82B	-145.2%	-32.6%	-39.9%	-$7.26
MGX	Metagenomi Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$25.21M	-$87.87M	-348.5%	-55.4%	-51.8%	-$2.36
MGTX	MeiraGTx Holdings plc Manufacturing · Year ended 2025-12-31 · USD	$81.39M	-$114.20M	-140.3%	n/a	144.6%	-$1.42
MAZE	Maze Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$131.12M	n/a	-36.9%	n/a	-$3.05
LXEO	Lexeo Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$99.96M	n/a	-40.5%	n/a	-$1.86
LONA	LeonaBio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$105.61M	n/a	-380.0%	n/a	-$24.70
LIMN	Liminatus Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.21M	n/a	n/a	n/a	-$0.43
LENZ	LENZ Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$19.09M	-$82.13M	-430.3%	-28.9%	n/a	-$2.85
LCTX	Lineage Cell Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.56M	-$63.53M	-436.5%	-146.6%	53.2%	-$0.28
KYTX	Kyverna Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$161.31M	n/a	-69.4%	n/a	-$3.64
KYMR	Kymera Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$39.21M	-$311.35M	-794.0%	-19.7%	-16.7%	-$3.69
KRYS	Krystal Biotech, Inc. Manufacturing · Year ended 2025-12-31 · USD	$389.13M	$204.83M	52.6%	16.8%	33.9%	$6.84
KOD	Kodiak Sciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$229.97M	n/a	-146.1%	n/a	-$4.32
KLRS	Kalaris Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$43.44M	n/a	-55.1%	n/a	-$2.85
JSPR	Jasper Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$75.80M	n/a	n/m	n/a	-$3.95
IVVD	Invivyd, Inc. Manufacturing · Year ended 2025-12-31 · USD	$53.43M	-$52.49M	-98.2%	-21.7%	110.5%	-$0.30
IPSC	Century Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$109.16M	-$9.58M	-8.8%	-6.0%	n/m	-$0.14
IOVA	Iovance Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$263.50M	-$390.98M	-148.4%	-56.0%	60.6%	-$1.09
INTS	Intensity Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.61M	n/a	-97.7%	n/a	-$8.56
INMB	Inmune Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$50.0K	-$45.93M	n/m	-195.3%	257.1%	-$1.86
INKT	MiNK Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.49M	n/a	n/a	n/a	-$2.93
INBX	Inhibrx Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.30M	-$140.06M	n/m	n/m	550.0%	-$9.04
INAB	IN8BIO, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.44M	n/a	-70.5%	n/a	-$4.44
IMVT	Immunovant, Inc. Manufacturing · Year ended 2026-03-31 · USD	n/a	-$505.61M	n/a	-59.3%	n/a	-$2.77
IMCR	Immunocore Holdings plc Manufacturing · Year ended 2025-12-31 · USD	$400.02M	-$35.51M	-8.9%	-9.3%	29.0%	-$0.71
IMA	ImageneBio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$800.0K	-$45.35M	n/m	-34.1%	-77.1%	-$9.64
IKT	Inhibikase Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$48.26M	n/a	-27.9%	n/a	-$0.49
IBRX	ImmunityBio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$113.29M	-$351.40M	-310.2%	n/a	668.3%	-$0.38
HUMA	Humacyte, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.04M	-$40.83M	n/m	n/m	n/a	-$0.26
HALO	Halozyme Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.40B	$316.89M	22.7%	649.2%	37.6%	$2.56
GRML	Greenland Mines Ltd Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.55M	n/a	-111.5%	n/a	-$0.22
GPLB	Green Planet Bio Engineering Co. Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$35.8K	n/a	n/a	n/a	$0.00
GLUE	Monte Rosa Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$123.67M	-$38.63M	-31.2%	-16.6%	63.5%	n/a
GILD	Gilead Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$29.44B	$8.51B	28.9%	37.6%	2.4%	$6.78
FENC	Fennec Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$44.64M	-$9.74M	-21.8%	-27.5%	-6.1%	-$0.34
FDMT	4D Molecular Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$85.21M	-$140.11M	-164.4%	-27.7%	n/m	-$2.42
FATE	Fate Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$6.65M	-$136.31M	n/m	-65.8%	-51.2%	-$1.15
EXOZ	Exozymes Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$9.16M	n/a	-269.6%	n/a	-$1.09
EXEL	Exelixis, Inc. Manufacturing · Year ended 2026-01-02 · USD	$2.32B	$782.57M	33.7%	36.2%	7.0%	$2.78
ESLA	Estrella Immunopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$13.06M	n/a	n/a	n/a	-$0.35
ENTX	Entera Bio Ltd. Manufacturing · Year ended 2025-12-31 · USD	$42.0K	-$11.44M	n/m	-87.3%	-76.8%	$0.25
ENGN	enGene Therapeutics Inc. Manufacturing · Year ended 2025-10-31 · USD	n/a	-$117.30M	n/a	-69.9%	n/a	$2.29
ELUT	Elutia Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$53.38M	n/a	192.9%	n/a	$0.87
ELOX	Eloxx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$6.00M	n/a	n/a	-100.0%	-$0.49
EDIT	Editas Medicine, Inc. Manufacturing · Year ended 2025-12-31 · USD	$40.52M	-$160.06M	-395.0%	-586.6%	25.4%	-$1.80
DYAI	Dyadic International Inc Manufacturing · Year ended 2025-12-31 · USD	$3.09M	-$7.36M	-238.3%	-597.6%	-11.6%	-$0.23
DTIL	Precision Biosciences Inc Manufacturing · Year ended 2025-12-31 · USD	$34.26M	-$45.72M	-133.4%	-49.6%	-50.1%	-$3.56

Rows per page: 25 50100